X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (42) 42
humans (42) 42
index medicus (42) 42
oncology (36) 36
ovarian cancer (28) 28
cancer (25) 25
middle aged (24) 24
aged (22) 22
immunohistochemistry (22) 22
ovarian neoplasms - pathology (21) 21
adult (20) 20
prognosis (19) 19
carcinoma (17) 17
ovarian carcinoma (17) 17
ovarian neoplasms - genetics (17) 17
mutation (15) 15
neoplasm staging (15) 15
obstetrics & gynecology (15) 15
pathology (15) 15
tumors (15) 15
aged, 80 and over (14) 14
chemotherapy (11) 11
surgery (11) 11
survival (11) 11
expression (9) 9
retrospective studies (9) 9
analysis (8) 8
endometrial cancer (8) 8
medicine & public health (8) 8
multivariate analysis (8) 8
prospective studies (8) 8
young adult (8) 8
cohort studies (7) 7
endometrial neoplasms - pathology (7) 7
neoplasm grading (7) 7
ovarian neoplasms - diagnosis (7) 7
ovarian neoplasms - drug therapy (7) 7
ovarian neoplasms - metabolism (7) 7
research (7) 7
biomarkers, tumor - genetics (6) 6
biomarkers, tumor - metabolism (6) 6
development and progression (6) 6
diagnosis (6) 6
dna mutational analysis (6) 6
kaplan-meier estimate (6) 6
ovarian neoplasms - surgery (6) 6
ovary (6) 6
risk factors (6) 6
article (5) 5
breast cancer (5) 5
cancer research (5) 5
carcinoma, ovarian epithelial (5) 5
cisplatin (5) 5
gene expression (5) 5
genetic predisposition to disease (5) 5
gynecology (5) 5
hematology (5) 5
medical prognosis (5) 5
ovarian neoplasms - mortality (5) 5
p53 protein (5) 5
pathogenesis (5) 5
predictive value of tests (5) 5
risk (5) 5
survival rate (5) 5
treatment outcome (5) 5
adenocarcinoma, mucinous - genetics (4) 4
biomarkers (4) 4
biomarkers, tumor - analysis (4) 4
carcinoma, endometrioid - pathology (4) 4
diagnosis, differential (4) 4
disease-free survival (4) 4
endometrial carcinoma (4) 4
follow-up (4) 4
forkhead box protein l2 (4) 4
forkhead transcription factors - genetics (4) 4
foxl2 (4) 4
further section (4) 4
further section · weitere sektionen (4) 4
gene-expression (4) 4
genetic aspects (4) 4
genetics (4) 4
granulosa cell tumor - genetics (4) 4
gynecologic-oncology-group (4) 4
health aspects (4) 4
heterogeneity (4) 4
internal medicine (4) 4
medical research (4) 4
mutations (4) 4
neoplasm invasiveness (4) 4
neoplasm, residual (4) 4
ovarian neoplasms - chemistry (4) 4
phenotype (4) 4
proportional hazards models (4) 4
survival analysis (4) 4
tp53 (4) 4
trial (4) 4
women (4) 4
adenocarcinoma (3) 3
adenocarcinoma, mucinous - diagnosis (3) 3
adenocarcinoma, mucinous - pathology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Southey, Melissa C and Goldgar, David E and Winqvist, Robert and Pylkäs, Katri and Couch, Fergus and Tischkowitz, Marc and Foulkes, William D and Dennis, Joe and Michailidou, Kyriaki and van Rensburg, Elizabeth J and Heikkinen, Tuomas and Nevanlinna, Heli and Hopper, John L and Dörk, Thilo and Claes, Kathleen BM and Reis-Filho, Jorge and Teo, Zhi Ling and Radice, Paolo and Catucci, Irene and Peterlongo, Paolo and Tsimiklis, Helen and Odefrey, Fabrice A and Dowty, James G and Schmidt, Marjanka K and Broeks, Annegien and Hogervorst, Frans B and Verhoef, Senno and Carpenter, Jane and Clarke, Christine and Scott, Rodney J and Fasching, Peter A and Haeberle, Lothar and Ekici, Arif B and Beckmann, Matthias W and Peto, Julian and dos-Santos-Silva, Isabel and Fletcher, Olivia and Johnson, Nichola and Bolla, Manjeet K and Sawyer, Elinor J and Tomlinson, Ian and Kerin, Michael J and Miller, Nicola and Marme, Federik and Burwinkel, Barbara and Yang, Rongxi and Guénel, Pascal and Truong, Thérèse and Menegaux, Florence and Sanchez, Marie and Bojesen, Stig and Nielsen, Sune F and Flyger, Henrik and Benitez, Javier and Zamora, M Pilar and Perez, Jose Ignacio Arias and Menéndez, Primitiva and Anton-Culver, Hoda and Neuhausen, Susan and Ziogas, Argyrios and Clarke, Christina A and Brenner, Hermann and Arndt, Volker and Stegmaier, Christa and Brauch, Hiltrud and Brüning, Thomas and Ko, Yon-Dschun and Muranen, Taru A and Aittomäki, Kristiina and Blomqvist, Carl and Bogdanova, Natalia V and Antonenkova, Natalia N and Lindblom, Annika and Margolin, Sara and Mannermaa, Arto and Kataja, Vesa and Kosma, Veli-Matti and Hartikainen, Jaana M and Spurdle, Amanda B and Investigators, kConFab and Wauters, Els and Smeets, Dominiek and Beuselinck, Benoit and Floris, Giuseppe and Chang-Claude, Jenny and Rudolph, Anja and Seibold, Petra and Flesch-Janys, Dieter and Olson, Janet E and Vachon, Celine and Pankratz, Vernon S and McLean, Catriona and Haiman, Christopher A and Henderson, Brian E and Schumacher, Fredrick and Le Marchand, Loic and Kristensen, Vessela and Alnæs, Grethe Grenaker and Zheng, Wei and Hunter, David J and ... and Australian Ovarian Canc Study Grp and kConFab Investigators and Australian Ovarian Cancer Study Group
Journal of Medical Genetics, ISSN 0022-2593, 12/2016, Volume 53, Issue 12, pp. 800 - 811
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2016, Volume 115, Issue 8, pp. 993 - 999
Journal Article
The Journal of Pathology, ISSN 0022-3417, 02/2016, Volume 238, Issue 3, pp. 389 - 400
Small cell carcinoma of the ovary, hypercalcaemic type ( SCCOHT ) is a lethal and sometimes familial ovarian tumour of young women and children. We and others... 
SMARCB1 | SWI | BRG1 | trichostatin A | SNF | rhabdoid tumour | epigenetic silencing | SMARCA2 | hypercalcaemic type | SMARCA4 | INI1 | inhibitor | small cell carcinoma | BRM | HDAC | SMARCA2/BRM | SMARCB1/INI1 | SMARCA4/BRG1 | SWI/SNF | HDAC inhibitor | DOWN-REGULATION | CYCLE ARREST | BRM EXPRESSION | PATHOLOGY | LUNG-CANCER | CD44 EXPRESSION | CANCER GENOMICS | BRG-1 | HIGH-GRADE | ONCOLOGY | NEUROENDOCRINE CARCINOMA | RHABDOID TUMOR | Immunohistochemistry | Carcinoma, Small Cell - genetics | Humans | Transcription Factors - deficiency | DNA-Binding Proteins - deficiency | DNA-Binding Proteins - metabolism | Ovarian Neoplasms - genetics | SMARCB1 Protein | Cell Transformation, Neoplastic - genetics | Nuclear Proteins - deficiency | Biomarkers, Tumor - metabolism | Female | Nuclear Proteins - genetics | DNA Helicases - genetics | Hypercalcemia - genetics | Chromosomal Proteins, Non-Histone - metabolism | Ovarian Neoplasms - diagnosis | Cell Proliferation - physiology | Adenosine Triphosphatases - metabolism | Nuclear Proteins - metabolism | DNA Helicases - deficiency | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Mutation - genetics | Carcinoma, Small Cell - diagnosis | Chromosomal Proteins, Non-Histone - deficiency | Chromosomal Proteins, Non-Histone - genetics | Transcription Factors - metabolism | DNA Helicases - metabolism | Cell Line, Tumor | Gene Silencing - physiology | Carcinoma | Sarcoma | Adenosine triphosphatase | Ovarian cancer | Cancer | Original Papers | Original Paper
Journal Article
British Journal of Cancer, ISSN 0007-0920, 08/2018, Volume 119, Issue 4, pp. 480 - 486
BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically... 
SURVIVAL | PATHWAYS | CELL-ADHESION MOLECULE | PREDICTOR | ONCOLOGY | L1 | GENE-EXPRESSION | GRADE | E-CADHERIN | PATHOLOGY | CANCER | Immunohistochemistry | Carcinoma | Risk groups | p53 Protein | Health risks | Multivariate analysis | Survival | Subgroups | Correlation analysis | Risk assessment | Endometrium | Tumors | Cancer | Biomarkers | Endometrial cancer | Outcomes research | Risk factors | Molecular medicine
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 9/2019, Volume 145, Issue 9, pp. 2251 - 2259
Fibroblast Growth Factor Receptor 4 (FGFR4) was proposed to hold prognostic significance in high-grade serous ovarian carcinoma (HGSOC). However, information... 
Prognosis | Medicine & Public Health | Hematology | Oncology | Cancer Research | Internal Medicine | FGFR4 | Ovarian cancer | TARGET | TRIAL | ADVANCED-STAGE | DES CANCERS | ONCOLOGY | INHIBITOR | PHASE-I | Immunohistochemistry | Viral antibodies | Tyrosine | Oncology, Experimental | Antibodies | Development and progression | Fibroblast growth factors | Research | Cancer
Journal Article
The Journal of Pathology, ISSN 0022-3417, 01/2013, Volume 229, Issue 1, pp. 111 - 120
Mucinous ovarian carcinomas ( MCs ) typically do not respond to current conventional therapy. We have previously demonstrated amplification of HER2 in 6 of 33... 
mutation | KRAS | HER2 | heterogeneity | Ovarian cancer | GYNECOLOGIC-ONCOLOGY-GROUP | IMMUNOHISTOCHEMICAL EXPRESSION | ANTI-EGFR THERAPY | PATHOLOGY | GROWTH-FACTOR RECEPTOR | ADVANCED-STAGE | ONCOLOGY | GASTRIC-CANCER | COLORECTAL-CANCER | ANTI-HER2 ANTIBODY | PREDICTIVE FACTORS | PATHOLOGISTS GUIDELINE RECOMMENDATIONS | Immunohistochemistry | Multivariate Analysis | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Receptor, ErbB-2 - genetics | United States | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Adenocarcinoma, Mucinous - chemistry | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Genetic Predisposition to Disease | Ovarian Neoplasms - chemistry | Risk Assessment | Biomarkers, Tumor - analysis | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Adenocarcinoma, Mucinous - secondary | Disease Progression | Adenocarcinoma, Mucinous - mortality | Canada | Disease-Free Survival | Phenotype | Gene Amplification | Adolescent | Aged | Biomarkers, Tumor - genetics | Adenocarcinoma, Mucinous - genetics | Mutation | Receptor, ErbB-2 - analysis | Australia | Neoplasm Staging | Multivariate analysis | Tumors
Journal Article
Journal Article
Journal Article
Tumor Diagnostik und Therapie, ISSN 0722-219X, 2015, Volume 36, Issue 3, pp. 157 - 161
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0186043
Journal Article